Skip to main navigation
Header Menu
Logo
  • About
    • Overview
    • Management
    • Board of Directors
  • Products
    • SYMJEPI® (epinephrine)
    • ZIMHI™ (naloxone)
  • Pipeline
  • Patients
  • Investors & Media
    • Overview
    • News Releases
    • Stock Information
    • SEC Filings
    • Events & Presentations
    • Email Alerts
    • Governance
  • Partnerships
  • Contact Us

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jun 17, 2022
Document Date
Jun 17, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Adamis Pharmaceuticals Corp
Issuer
ADAMIS PHARMACEUTICALS CORP

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT

Sign Up For Adamis Pharmaceuticals Email Alerts

Choose Your Preferences
Adamis

Adamis Pharmaceuticals is a clinical stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs.

02. Footer - Social Links
  • LinkedIn
  • Twitter
Footer - Column 2
COMPANY
  • About Us
  • Overview
  • Management
  • Board of Directors
Products
  • SYMJEPI® (epinephrine)
  • ZIMHI® (naloxone)
Pipeline
  • Specialty Pharmaceuticals
  • APC-400 (tempol) – Capsule
Footer - Column 3 (Hidden on Desktop)
Investors & Media
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events & Presentations
  • Email Alerts
  • Corporate Governance
Connect
  • Careers
  • Partnerships
  • Contact Us
Footer - Column 4
Products
  • SYMJEPI® (epinephrine)
  • ZIMHI® (naloxone)
Pipeline
  • New Molecular Entities
Footer - Column 5
Investors & Media
  • Overview
  • News Releases
  • Stock Information
  • SEC Filings
  • Events & Presentations
  • Corporate Governance
  • Email Alerts
Footer - Column 6
Connect
  • Careers
  • Partnerships
  • Contact Us

© 2023 Copyright Adamis Pharmaceuticals Corp

Footer Copyright Links
  • Terms and Conditions
  • Privacy Policy